The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Price to Sales Analysis
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
The most important factor to remember is that the price of equity takes a firm's debt into account, whereas the sales does not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Based on latest financial disclosure the price to sales indicator of CVS Health Corporation is roughly 0.38 times. This is 98.22% lower than that of the Healthcare sector, and significantly higher than that of Healthcare Services industry, The Price to Sales for all stocks is 97.87% higher than the company.
CVS Health Price to Sales Comparison
CVS Health is rated fourth in price to sales category among related companies.